Answers are grounded in this paper and cite their sources.
Background: The female breast is subjected to a life time of hormonal controls, whose effect is evident at the time of menarche and during the menstrual cycle, pregnancy and lactation.Studies have reported multiple risk factors for breast cancer, some of which are a reflection of hormonally mediated events.The steroid receptors are also served as prognostic factors for evaluating the status of malignant tumor of the breast.Estrogen receptor (ER) and progesterone receptor (PgR) formation are influenced by estrogen and progesterone concentration.The aim of this study was to clarify the hormonal milieu of the breast cancer such as Estradiol (E2), Progesterone (Pg), Prolactin (PRL) and their correlation with prognostic factors like ER, PgR. Materials and Methods:In this study, we examined fourthy-four samples removed from patients with primary breast cancer by radical mastectomy.The specimens include thirty six malignant and eight benign breast tissues.Blood samples were also obtained before surgery.Steroid receptors was assayed by the method of single-point dextrane-coated charcoal (DCC), hormones by radioimmunoassay.Results: The beating area percentage of EBs in OT treatment group was more than that of the 5Az group in all days of experiment.However, only in final stage, a significant increase was observed in beating area of OT group.There was no significant difference in viability and morphological changes.OT induction expressed three more specific proteins in cell culture than 5Az.Conclusion: Statistical analysis revealed that response to OT inducer was more excessive than 5Az in all treatment groups.The Oxytocin was found to be effective inducer of cardiomyocytes differentiation from embryonic carcinoma cells P19 than 5-azacytidine.
No takes yet. Share an insight, caveat, or question.
Mehryar Zargari (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: